A Proof-of-concept Study of Lunsekimig Compared With Placebo in Adults With Chronic Rhinosinusitis With Nasal Polyps

Investigational Site Number : 0320001, Buenos Aires

Investigational Site Number : 1000001, Sofia

Investigational Site Number : 0320002, Rosario

Investigational Site Number : 0560001, Leuven

Investigational Site Number : 0320003, Mendoza

Investigational Site Number : 0560002, Ghent

Eastern Virginia Medical School (EVMS) Medical Group- Site Number : 8400008, Norfolk

Emory University Hospital Midtown- Site Number : 8400012, Atlanta

James A Haley Veterans' Hospital- Site Number : 8400015, Tampa

Essential Medical Research- Site Number : 8400020, Tulsa

Berkson Medical - McKinney- Site Number : 8400014, McKinney

Gary Gross Pharmaceutical Research & Consulting, Inc. Site Number : 8400004, Dallas

McGovern Medical School - UT Physicians Dermatology - Bellaire Station- Site Number : 8400017, Bellaire

Alamo ENT Associates Site Number : 8400001, San Antonio

The Allergy Group - Asthma & Allergy Boise- Site Number : 8400002, Boise

Advanced Research Institute - Odgen- Site Number : 8400022, Ogden

Senta Clinic- Site Number : 8400025, San Diego

Allergy & Rheumatology- Site Number : 8400005, La Jolla

Sacramento Ear Nose & Throat - Roseville- Site Number : 8400003, Roseville

Harvard Medical School - Brigham and Women's Hospital Site Number : 8400016, Boston

Investigational Site Number : 6160002, Krakow

Investigational Site Number : 6160001, Warsaw

Investigational Site Number : 6160005, Warsaw

Investigational Site Number : 6160003, Katowice

Investigational Site Number : 6160004, Poznan

Investigational Site Number : 6160007, Wroclaw

Investigational Site Number : 8260004, Gloucester

Investigational Site Number : 8260003, Manchester

Investigational Site Number : 8260001, Newcastle upon Tyne